Bacteriophage FNU1 negates Fusobacterium nucleatum induced cell growth, migration and chemotherapy resistance in gastrointestinal cancer cells
Treatments with bacteriophage FNU1, therefore, have the potential to augment existing cancer therapy, and further testing in animal models is warranted.
Authors
- Birhanu Ayelign (ORCID: https://orcid.org/0000-0001-9157-3637)
- Joseph Tucci (ORCID: https://orcid.org/0000-0002-4495-6931)
- Mwila Kabwe (ORCID: https://orcid.org/0000-0002-6321-9080)
- Michael Büchert (ORCID: https://orcid.org/0000-0003-2672-0148)
- Shoukat Afshar-Sterle
Institutions
- La Trobe University (AU)
- Olivia Newton-John Cancer Wellness & Research Centre (AU)
Publication Details
- Journal
- Frontiers in Cellular and Infection Microbiology
- Published
- 2026-01-08
- DOI
- https://doi.org/10.3389/fcimb.2025.1721411
- Primary Topic
- Bacteriophages and microbial interactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00